02:02:17

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Manageme...

02:02:17

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Manageme...

02:01:57

Striving for Consensus: Current and Future Management of HER2-Low and HER2-Ultralow Breast Cancer

01:58:47

The Application of Available Research to the Clinical Care of Patients with Hepatocellular Carcinoma

01:58:48

Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 Asco GI...

46:46

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

10:06

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Manage...

10:06

Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

10:06

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Manage...

01:00:02

Clinical Investigator Perspectives in EGFR-Mutant Non-Small Cell Lung Cancer

32:11

Management of Metastatic EGFR Mutation-Positive NSCLC — Enriqueta Felip, MD, PhD

36:16

Other Relevant Topics in EGFR Mutation-Positive NSCLC — Helena Yu, MD

01:00:03

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

46:46

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

46:31

Optimizing the Selection of First-Line Therapy for Patients with Multiple Myeloma

28:29

Optimizing the Selection of First-Line Therapy for Patients with Multiple Myeloma (Video Lecture)

11:58

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Manage...

11:58

Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 3

11:58

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Manage...

59:28

Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series

59:28

Optimizing the Management of Chronic Lymphocytic Leukemia — Part 3 of a 3-Part Series

59:28

Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series

01:00:17

Oncology Q&A: Addressing Questions from Patients with Metastatic Triple-Negative Breast Cancer

01:00:17

Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questio...

01:00:17

Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questio...

59:33

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients w...

59:33

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients w...

01:00:59

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

01:00:59

Common Questions Posed by Patients with Metastatic Triple-Negative Breast Cancer

01:00:59

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

02:00:29

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite S...

02:00:29

Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

02:00:29

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite S...

01:59:15

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:59:15

Addressing Current Questions and Controversies in the Management of Myelofibrosis

01:59:15

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

02:01:00

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

02:01:00

Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer

02:01:00

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

01:27:00

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:27:00

Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia

01:27:00

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:58:51

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:58:51

Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

01:58:51

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

02:00:37

Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer

02:00:37

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 sympos...

02:00:37

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposi...

01:31:29

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

01:31:29

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

01:31:29

Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

01:57:11

Addressing Current Questions and Controversies in the Management of Multiple Myeloma

01:57:11

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:57:11

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:57:08

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

01:57:08

Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

01:57:08

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

49:11

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal an...

55:50

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary...

51:44

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis